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Abstract 
Background: To determine relationship between 
the levels of serum Lactate Dehydrogenase (LDH)on 
admission and prognosis of dengue fever. 
Methods: Patients (n=62) admitted with the 
diagnosis of dengue fever were included. On 
admission, serum LDH levels were measured in all 
patients and to find relationship we monitored all 
patients upto discharge. Monitoring was done for 
vitals, different blood parameters and duration of 
hospitalization. 
Results: Forty one (66.1%) were males and 33.9% 
(n=21) were females with mean age 
31.73±13years.During hospital stay, 61.3% patients 
had Dengue fever (DF)while 39.7% patients 
developed dengue hemorrhagic fever (DHF).LDH 
levels were higher in patients with DHF(mean 
618.38U/L±219)as compared to the patients with 
dengue fever (mean 316.45U/L±104).Mann Whitney 
U test showed the difference was statistically 
significant (p<0.001). 
Conclusion: Patients with early increase in serum 
LDH showed more complications as compared to 
low serum LDH level. High LDH can be used to 
predict outcome in dengue patients. 
Keywords: Lactate dehydrogenase, Dengue fever 
(DF), Dengue hemorrhagic fever (DHF), Dengue 
shock syndrome (DSS) 
Introduction 
Dengue is a vector borne disease epidemic with high 
morbidity and mortality. This disease is caused by 
dengue virus having 4 serotypes DENV-1 to 4.1   It is 
mainly transmitted to humans by bite of female Aedes 
aegypti and Aedes albopictus mosquito but it can also 
be transmitted through blood transfusion, trans 
placental route, organ transplantation and needle stick 
or sharps injuries. 2-6 It is the most prevalent epidemic 
nowadays, across the world and especially in the Asia. 
It affects about 50-100 million people per year as per 
WHO statistics. 7 In Pakistan, first dengue epidemic 
was reported in 1994. 8 During 2011 dengue outbreak 
in Pakistan there were more than 20,000 cases and 300 
deaths reported. 9 
Dengue has varied clinical manifestations ranging 
from mild flu like symptoms, fever, arthralgia, 
myalgia, mild GI symptoms to potentially fatal 
complications of vascular leakage. It can be detected in 
asymptomatic case or may present as undifferentiated 
fever, Dengue fever (DF), Dengue hemorrhagic fever 
(DHF), dengue shock syndrome (DSS) and Expanded 
dengue syndrome (EDS).  10 While DF is a mild, self-
limiting disease DHF and DSS may be fatal if not 
diagnosed and treated timely and appropriately. 
Dengue passes through three clinical stages; Febrile 
phase which may last for 2 to 10 days after which 
patient may enter Recovery phase characterized by 
resolution of fever and other associated symptoms, or 
patient may progress into Critical phase marked by 
resolution of fever and appearance of fluid 
leakage(10). Most of the complications of dengue occur 
around the period of defervescence. 11 
Dengue causes micro vascular inflammation 
throughout the body, as evidenced by the increased 
markers of inflammation e.g. cytokines, chemokines, 
VEGF and other angiogenic factors. 12-18 Injury to 
vascular endothelial cells results from a complex 
interaction between the circulating proteins of dengue 
virus and host immune response. Activation of cellular 
and humoral immune response increasesvascular 
permeability, which may be manifested by ascites, 
pleural effusion or shock. 19 
Lactate dehydrogenase (LDH) is an intracellular 
enzyme abundantly found in body tissues e.g. 
muscles, liver, placenta, RBCs, reticuloendothelial 
system. Its serum levels increase after cell injury.It has 
been evaluated as prognostic marker of various 
inflammatory states e.g. sepsis, infections,MI, 
malignancies  and cardio-pulmonary compromise. It is 
thought to be a marker of vascular permeability in 
immune mediated lung injury. 20-24  Serum LDH levels 
are increased in DF. Various studies show that LDH 
levels are higher in DHF and DSS patients. 25-28 An 
early increase in LDH (three times the normal value) 
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was an independent predictor of DHF. 29Dengue has 
very high rate of admission in tertiary care hospitals. 
Severe dengue requires aggressive monitoring, thus 
posing a burden on health system. So, the search for 
the prognostic factors, may help to reduce the rate of 
hospitalizations, as well as disease mortality and 
morbidity. This study evaluated the relation of at 
admission serum LDH levels with severity of DF. 
Patients and Methods 
This cross sectional comparative study was carried out 
from 5thSeptember 2016 to 27th November 2016 in the 
Dengue Inpatient Department of Benazir Bhutto 
Hospital (BBH),Rawalpindi. We included the patients 
aged 18 to 80 years, admitted consecutively with 
probable DF and having positive NS1 antigen and/or 
dengue IgM. Patients with negative dengue serology, 
taking anti-platelet medications, having platelet 
disorder, hemolytic anemia or co morbidities (like 
IHD, hepatitis due to non-dengue cause, pancreatitis, 
chronic renal or liver disease) and infections other than 
dengue were excluded. Patients were managed as per 
standard guidelines of Dengue expert advisory 
group(DEAG) and were categorized as DF and 
DHF(30)as described below.DF was defined as fever of 
2-7 days with at least two of the following- headache, 
retro-orbital pain, arthralgia/bone pain, 
myalgia,Rash,leucopenia (TLC of less than 5*109), 
thrombocytopenia (platelets less than 150,000/ul) 
without any evidence of plasma leakage.DHF was 
defined as fever with bleeding, 
thrombocytopenia(platelets less than100,000/ul) and 
plasma leakage as indicated by one of the following 
>20% increase in haematocrit from baseline, >20% 
decrease in haematocrit after IV fluids or imaging 
evidence of plasma leakage e.g. ascites, pleural 
effusion, GB wall thickness or pericholecystic fluid. 
Serum LDH levels of less than 200 units/ liters were 
considered normal. Patients were divided into two 
groups depending upon their disease outcome. Group 
1 included the patients who had DF. Whereas, Group 2 
consisted of the patients who progressed to DHF. A 
structured Performa was developed and used for data 
collection. Data was analyzed using SPSS 24 version. 
LDH levels were compared between the two groups 
by Mann Whitney U test, and chi square test was 
applied wherever appropriate. 
Results 
Sixty-two patients were included in the study. Male 
were predominant (Table 1). Male to female ratio was 
1.94:1 in study population, 1.5:1 in group 1 and 3:1 in 
group 2. Mean LDH level of the study population was 
433.32±216 U/L. LDH levels were quantitatively 
higher in group 2 as compared to group (Table 2). 
Patients were further stratified according to their LDH 
levels into three categories and compared between the 
two groups (Table 3). 
Table 1- Demographic profile of the patients. 
 Total  
n=62  
Group 1  
61.3%(n=38)  
Group 2  
38.7%(n=24)  
p- value 
Mean 
Age 
(Years)  
31.7 
±13.40  
32.47±14.67 30.54±11.30  0.822 
Male 
No (%) 
41(66.1) 23(60.53)  18(75)  0.041 
Duration 
of fever* 
(Mean± 
SD) 
5.21±1.92  5.21±1.92  5.21±1.97  0.997  
Duration 
of 
hospital 
stay* 
(Mean ± 
SD) 
3.53±1.43  3.6±1.41  3.3±1.46  0.390  
*In days. 
 
Table 2- Comparison of mean serum LDH levels 
between the two groups 
D i s e a s e  G r o u p LDH levels on admission   
( U / L )   
 
p value 
Group 1 (Mean ± SD)  3 1 6 . 4 5 ± 1 0 4  
<0.001 Group 2 (Mean ± SD)  6 1 8 . 3 8 ± 2 1 9 
 
Table 3: Group wise comparison  
of LDH categories. 
LDH levels U/L  
D i s e a s e  G r o u p 
P  v a l u e 
Group 1  Group 2   
Less than 200  15.8%(n=6)  0 %    
 
< 0 . 0 0 1 
2 0 0  t o  6 0 0   73.8%(n=31)  26.2%(n=11)  
More than 600  7.1%(n=1)  92.9%(n=13)  
 
Discussion 
Many studies show that serum LDH levels are raised 
in DF but there are very limited studies evaluating it 
as a prognostic marker in this disease. No study has 
been found in Pakistan regarding the prognostic role 
of LDH in dengue. In this study, it was notedthat LDH 
levels are elevated to more than 200 U/L inall of the 
DHF patients and majority of DF patients. LDH levels 
at admission were significantly higher in patients who 
progress to DHF (618.38 ±219U/L)as compared to 
those withsimple DF (316.45 ±104U/L), p<0.001. These 
results are similarto those reported by Sirikutt et al 
and Villar-Centeno et al although mean levels in this 
study are lower in each group than reported in 
abovementioned studies, While Liao B et al reported 
slightly lower levels in both DF and DHF, 213.68 U/L 
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and 448.17 U/L respectively. 25,26,29,30 Patients in Group 
2 had 3-fold increase in LDH levels. It was noted that 
although some patient with simple DF had normal 
values of serum LDH, whereas, none of the patients in 
group 2 was found to have normal LDH levels. In 
majority of group 2 patients (92%) LDH levels were 
more than 600 units/liter, as reported by Ravishankar 
et al. 31 
In our study, majority of the patients were males 
(65.3% in group 1 and 75% in group 2), matching those 
reported in WHO surveillance data and study done by 
Agarwal et al, the reason for this gender difference is 
not clearly understood but may be due to the greater 
exposure of males to mosquitoes due to theiroutdoor 
occupational activities. 32-34  We found that males are 
more likely to develop severe form of the disease as 
reflected by the differences in gender ratios between 
the two groups, literature has controversial results 
about this relation, results of Vicente CR et al(35) favor 
our finding. 35 Whereas,Villar-Centeno andRasul CH 
et al found no gender differences between those 
developing DHF as compared to those who did not. 
29,36 
Mean age of our patients was 31.7 ±13.4 years which 
was slightly higher than that mentioned by Villar-
Centeno(29). Patients in DHF group were relatively 
younger than DF group but the difference was not 
statistically significant(p-value 0.82) whereas, previous 
study reported higher age in patients with severe 
dengue.35  
In our study mean duration of illness at the time of 
presentation was 5.21 days, while duration of 
hospitalization was 3.53 days, there was no difference 
between the two groups regarding these parameters 
with p values of 0.997 and 0.390 respectively. Similar 
results are reported in previous studies. 29 But this was 
a small study with a relatively small sample size, 
carried out on relatively healthy adults without any 
major co morbidities. Single sample for LDH levels 
was on average sought on 5th day of fever. Critical 
Phase in dengue usually extends from 3 to 7 days, 
seeking LDH levels at this time may have maximum 
impact. Moreover, this study only included patients 
admitted in a tertiary care hospital, which mostly 
represent most severe form of disease. So, further 
larger prospective studies including the populations 
missing in this study at earlier stages of disease, are 
required to test this association. 
Conclusion 
1.  Serum LDH levels were  found elevated in DHF patients. 
This correlation may be used as a predictor for severity 
in DF. Elevated levels of LDH on day 5 in dengue fever 
point towards the diagnosis of DHF. A cut off value of 
more than 600 U/L was seen in majority of these 
patients. 
2.  Biomarker, like LDH, can lead to  the establishment of 
predictors of dengue severity that is very important to 
control disease and reduction in morbidity and 
mortality caused by this disease. 
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